MICHAEL D BLASZYK
CIK 1371407 · last filed 2026-06-10
MICHAEL D BLASZYK is a corporate insider who has filed 20 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for IBRX, was dated Jun 10, 2026. Across all open-market trades the lifetime net is +$198.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.89M
4
20
$198.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IBRX | Director | 265,582 | $7.10 | $1.89M | $198.0K | 7 | 2026-06-10 |
| NantHealth, Inc. (NH) Delisted | Director | 95,870 | $1.35 | $129.4K | $0 | 6 | 2022-06-10 |
| ImmunityBio, Inc. (NK) Delisted | Director | 193,667 | — | — | $0 | 5 | 2020-06-11 |
| APP Pharmaceuticals, Inc. (ABII) Delisted | Director | — | — | — | $0 | 2 | 2008-09-15 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | IBRX | Buy (P) | +71,915 | $198.0K | EDGAR |
| 2022-06-15 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | NantHealth, Inc. (NH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-26 | NantHealth, Inc. (NH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | IBRX | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | ImmunityBio, Inc. (NK) Delisted | Grant (A) | — | $0 | EDGAR |